(Date:12/3/2008)...FORE"...Though they may not help improve a person,...ay golfers think about the local country club in t...ouri study. , "There are more than 17,000 golf c...percent of that land is not used for playing," sai... the MU College of Arts and Science. "These manage...
(Date:12/3/2008)...EMBER 1, 2008 -- As the United States continues to...ds energy independence, cellulosic-based ethanol h...technologies. Corn stover remains the most popular...rbon (SOC) associated with the removal of corn fod...ltural and environmental concern. , In the Nov...
(Date:12/3/2008)...roblem of children failing to take their medicatio...be tackled as part of a new university research pr...cialists at The University of Nottingham and The U...s of school children with asthma, diabetes, congen... barriers that prevent them from taking medicines ...
(Date:12/3/2008)...ion team of investigators led by researchers at th...thern California (USC) has received $19 million in...alth (NIMH) for a groundbreaking effort to collect...nts in order to study the genetic risks for schizo...for Genomic Psychiatry and Massachusetts General H...
Breaking Biology News(10 mins):Golf course: Playing fields, wildlife sanctuaries or both 2Managing carbon loss 2A spoonful of sugar? 2A spoonful of sugar? 3USC researchers head global effort to study genetic risks that contribute to psychiatric diseases 2USC researchers head global effort to study genetic risks that contribute to psychiatric diseases 3Catalyst Pharmaceutical Partners to Present at the Rodman 26 Renshaw 10th Annual Global Investment Conference 8813 1Catalyst Pharmaceutical Partners to Present at the Rodman 26 Renshaw 10th Annual Global Investment Conference 8813 2MiddleBrook Pharmaceuticals Retains National Account Firm VCG 26 Associates 28516 1MiddleBrook Pharmaceuticals Retains National Account Firm VCG 26 Associates 28516 2MiddleBrook Pharmaceuticals Retains National Account Firm VCG 26 Associates 28516 3Survey Reveals Consumer Interest in New Media Formats for Health Information From Hospitals 28515 1Survey Reveals Consumer Interest in New Media Formats for Health Information From Hospitals 28515 2Survey Reveals Consumer Interest in New Media Formats for Health Information From Hospitals 28515 3Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at AASLD 2008 8808 1Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at AASLD 2008 8808 2Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at AASLD 2008 8808 3Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at AASLD 2008 8808 4(Date:12/4/2008)...oduces New Trade Name Onrigin(TM) for Laromustine ...rstCall/ -- VION PHARMACEUTICALS, INC. (OTC Bulle... related to events in connection with the 50th Ame...Moscone Center in San Francisco from December 6-9,..., , The Company announced that it would pres...
(Date:12/4/2008)...4 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (...ical company focused on endocrine therapy and onco...Juergen Engel, Ph.D., will take part in a panel di...r And Better Agents" at the upcoming RBC Capital M...cember 10, 2008 at 4:30 pm (eastern time) at the W...
(Date:12/3/2008)...-known dangers of first- and secondhand smoke, an .... are smokers. Exposure of a developing baby to h... affects an estimated 420,000 newborns each year a..., in the first study of its kind, a team of resear...s, umbilical cord blood to better understand the f...
(Date:12/3/2008)...3 CeloNova BioSciences, Inc., anno...ch it is commercializing the,CATANIA(TM) Coronary...nt,system that has not had any stent thrombosis i... for purchase throughout Europe and now some Middl...pansion ongoing. Concurrently,CeloNova notes tha...
Breaking Biology Technology:Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 3Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 4Cutting the cord to determine babies' health risk from toxic exposure 2Cutting the cord to determine babies' health risk from toxic exposure 3Cutting the cord to determine babies' health risk from toxic exposure 4CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 2CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 3... , , , , , , This applic...ty of,absolute protein quantitation of the Agile...ein 200 Plus assay to the batch-based methods,Lo...rophoresis (SDSPAGE).,The results showed that th...iable absolute quantitation data comparable to the...
...expert software , Powerful software for th...he Agilent 2100 bioanalyzer , , , , ...is a,unique, on-chip, electrophoresis and,flow...nd cells., , , Agilents single software ...software for the 2100 bioanalyzer ,incorporating...
... , , , , , , A fast and ...n,expression in samples of low cell numbers ,...he major problems,that many researchers working,...availability, quantity,and lifespan. Using the A...LabChip kit the transfection,efficiency of prima...
... , , , , , , This Applic...zer and,the Cell Fluorescence LabChip kit can be...n of mammalian cells using green fluorescent prote... CHO-K1 cells with,expression vectors encoding G...of transfection conditions for both plasmids were ...
Other Biology Technology:Comparison of different protein,quantitation methods 2Comparison of different protein,quantitation methods 3Comparison of different protein,quantitation methods 4Comparison of different protein,quantitation methods 5Comparison of different protein,quantitation methods 6Comparison of different protein,quantitation methods 7Comparison of different protein,quantitation methods 8Comparison of different protein,quantitation methods 92100 expert software , Powerful software for the analysis of RNA, DNA, proteins, and cells with the Agilent 2100 bioanalyzer 2Flow cytometric analysis of human,primary cells using the Agilent 2100,bioanalyzer and on-chip staining 2Flow cytometric analysis of human,primary cells using the Agilent 2100,bioanalyzer and on-chip staining 3Monitoring transfection efficiency by,green fluorescent protein (GFP) detection,with the Agilent 2100 bioanalyzer 2Monitoring transfection efficiency by,green fluorescent protein (GFP) detection,with the Agilent 2100 bioanalyzer 3Monitoring transfection efficiency by,green fluorescent protein (GFP) detection,with the Agilent 2100 bioanalyzer 4Monitoring transfection efficiency by,green fluorescent protein (GFP) detection,with the Agilent 2100 bioanalyzer 5Monitoring transfection efficiency by,green fluorescent protein (GFP) detection,with the Agilent 2100 bioanalyzer 6Monitoring transfection efficiency by,green fluorescent protein (GFP) detection,with the Agilent 2100 bioanalyzer 7Human Interferon (IFN) and Receptor, PCR Array for expression profiling from SuperArray Bioscience
Silencer siRNA Starter Kit from Ambion
EDG-6 Lysate from Exalpha Biologicals, Inc.
Mouse monoclonal [F30 P7 D7 F5] to RYK ( Abpromise for all tested applications). Antigen: Synthetic peptide: CLTEFHAALGAYV conjugated to Ovalbumin, corresponding to amino acids 462 - 475 of RYK.
Biology Products: